Thai FDA Medical Device process has changed.  Thai FDA’s recent decision to terminate the medical device CSDT dossier in “partial 2” submission has sent ripples through the healthcare industry. With only the “full submission” option remaining effective from February 14, 2024, medical device manufacturers and stakeholders are facing a paradigm shift in regulatory compliance and … Continue reading Thai FDA Medical Device: Understanding the Impact of Partial 2 Submission Termination